Joseph J. Eron

Research topics

• HIV Research and Treatment · 4 papers
• HIV/AIDS drug development and treatment · 4 papers
• HIV/AIDS Research and Interventions · 3 papers
• HIV-related health complications and treatments · 1 paper

Frequent co-authors

• Diane V. Havlir · 2 papers
• Scott M. Hammer · 2 papers
• Jeffrey Chodakewitz · 2 papers
• Douglas D. Richman · 2 papers
• Myron S. Cohen · 1 paper
• Ying Qing Chen · 1 paper
• Marybeth McCauley · 1 paper
• Theresa Gamble · 1 paper

Papers

1. Prevention of HIV-1 Infection with Early Antiretroviral TherapyNew England Journal of Medicine · 2011 · 7,006 citations

   BACKGROUND: Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. METHODS: In nine countries, we enrolled 1763 couples in which one partner was HIV-1-positive and the other was HIV-1-negative;…

2. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine · 1997 · 2,688 citations

   BACKGROUND: The efficacy and safety of adding a protease inhibitor to two nucleoside analogues to treat human immunodeficiency virus type 1 (HIV-1) infection are not clear. We compared treatment with the protease inhibitor indinavir in addition to zidovudine and lamivudine…

3. Antiretroviral Treatment of Adult HIV InfectionJAMA · 2012 · 2,475 citations

   CONTEXT: New trial data and drug regimens that have become available in the last 2 years warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected adults in resource-rich settings. OBJECTIVE: To provide current recommendations for…

4. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine · 1997 · 1,925 citations

   BACKGROUND: The new protease inhibitors are potent inhibitors of the human immunodeficiency virus (HIV), and in combination with other antiretroviral drugs they may be able to cause profound and sustained suppression of HIV replication. METHODS: In this double-blind study, 97…